Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential
Current Issues in Molecular Biology · 18.08.2025 · 47 (8) · 667
DOI: 10.3390/cimb47080667 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 18.08.2025. Verfasst von Cristina Cueto-Ureña und 3 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Jaén, E-23…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Central nervous system (CNS) tumors, especially gliomas and IDH-wildtype glioblastoma, present high aggressiveness, low response to current treatments and limited survival. Several biological processes such as oxidative stress, inflammation, apoptosis, and autophagy are involved in their development. Hydroxytyrosol (HTX), a phenolic compound present in olives, has shown relevant effects on these processes in experimental models. This review analyzes its chemical characteristics, bioavailability, and ability to cross the blood–brain barrier, as well as its mechanisms of action. Despite its rapid metabolism, HTX can reach the brain in small but functional amounts, and various formulation methods can enhance its delivery to nervous tissue. HTX acts on cellular pathways such as Nrf2, NF-κB, JAK/STAT, PI3K/Akt and SIRT1, regulating redox balance, inflammation, programmed cell death, and autophagy. It can also influence gene expression through epigenetic mechanisms. In cell models, it has shown inhibitory effects on tumor growth and activation of apoptosis, without affecting non-tumor cells. These results support its possible usefulness as an adjunct in the treatment of brain tumors, although further studies in animal and human models are required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Jaén, E-23071 Jaén, Spain.
ORCID-Profile: Cristina Cueto-Ureña, María Jesús Ramírez-Expósito, María Pilar Carrera-González, José Manuel Martínez-Martos
Zitieren
APA
Cueto-Ureña, C., Ramírez-Expósito, M. J., Carrera-González, M. P., & Martínez-Martos, J. M. (2025). Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential. Current Issues in Molecular Biology, 47(8), 667. https://doi.org/10.3390/cimb47080667
Vancouver
Cueto-Ureña C, Ramírez-Expósito MJ, Carrera-González MP, Martínez-Martos JM. Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential. Current Issues in Molecular Biology. 2025;47(8):667. doi:10.3390/cimb47080667
BibTeX
@article{CuetoUrea2025,
author = {Cueto-Ureña, Cristina and Ramírez-Expósito, María Jesús and Carrera-González, María Pilar and Martínez-Martos, José Manuel},
title = {Hydroxytyrosol and Brain Tumors: Mechanisms of Action and Therapeutic Potential},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {8},
pages = {667},
doi = {10.3390/cimb47080667}
}
EUVIMED